Business
STAAR Surgical Experience Center Expands to Meet Growing Surgeon Demand
State-of-the-Art Facility Elevates Ophthalmic Education, Empowering Surgeons and Practitioners to Lead the Future of Vision Correction Myopia in the U.S. has
About this update from Staar Surgical Company
[{"type":"text","content":"\nState-of-the-Art Facility Elevates Ophthalmic Education, Empowering Surgeons and Practitioners to Lead the Future of Vision Correction\n\n\nMyopia in the U.S. has doubled over the past three decades with an expected prevalence of 58.4% by 2050 1\n\n\nEVO ICLTM units, a proxy for procedures, grew by 25% in the U.S. in 1H 20242\n\n\nMore than 700 U.S. surgeons are now certified by STAAR Surgical to perform EVO ICL2\n\n\n LAKE FOREST, Calif.--(BUSINESS WIRE)--\n\nSTAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICLTM) for myopia, astigmatism and presbyopia, is proud to announce the expansion and new location of the STAAR Surgical Experience Center. Located at STAAR’s headquarters in Lake Forest, California, near John Wayne Airport (SNA), the center serves as a dynamic hub for comprehensive, hands-on training and education in lens-based vision correction.\n\nThe new Experience Center is a critical addition to customer training, education and support as the demand for EVO ICL continues to surge among surgeons and refractive practices, driven by the escalating global myopia epidemic. The prevalence of myopia in Americans is 42%3, having doubled over the past three decades3, while laser refractive procedure volume is declining. EVO ICL is rapidly disrupting the refractive market. STAAR Surgical is on track to sell more ICLs between 2024 and 2026 than in the first 25 years of ICL sales combined, reflecting the transformative impact of this technology following FDA approval and market launch.\n\n“We are thrilled to open our expanded Experience Center, offering cutting-edge resources and training for ophthalmic professionals,” said Tom Frinzi, President and CEO of STAAR Surgical. “The center reflects our commitment to supporting the growing demand for EVO ICL and advancing its global adoption.”\n\nThe Experience Center elevates the standard of care by equipping healthcare practitioners—MDs, ODs, and support staff—with the tools and knowledge to optimize EVO ICL patient outcomes. It offers advanced visualization and communication technology for both in-person and virtual training. Highlights include:\n\n\nImmersive wet lab training stations for up to 24 practitioners, with seating for 59 in lectures\n\n\nStella™, STAAR’s latest innovation in order...